Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Useful patient resource during GLP-1 shortage
Long-Term Use Semaglutide: Has shown promise for long-term weight management, but continuous use is required to maintain weight loss
But one finding stood out during my research
[15] Coverage may continue for type 2 diabetes indication Separate from Highmark policies in PA What This Means for You Check your specific plan: Coverage varies by state, employer, and plan typedon't assume During open enrollment: If your BCBS plan is dropping coverage, explore other insurer options Self-funded employers: Ask HR if your employer is opting to continue GLP-1 coverage Consider alternatives: If you have Type 2 diabetes, Mounjaro (same active ingredient) may still be covered CV indication not yet covered: Despite Lilly's cardiovascular benefits data, no BCBS plans currently cover Zepbound for heart disease or CV risk reductionmost explicitly exclude it [16] CALL YOUR INSURANCE Verify Your Specific Coverage Verify Your Specific Coverage Even though it takes a little more time, we recommend calling so you can speak with a person who may have more information than the online directory or PDF formulary listing
